[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Contraception |
Condom; Condoms |
Clinical Trial: Emergency Contraception (ECP): Reducing Unintended Pregnancies
This study has been completed.
|
Purpose
Emergency contraception is a method of birth control that can be used up to three days after sexual intercourse. Emergency contraceptive pills (ECPs) can be given to a woman before she needs them (advance provision) or when she needs them (emergency provision). This study will compare these two methods of providing ECPs.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Contraception Pregnancy | Drug: emergency contraception (estrogen/progesterone) | Phase IV |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Prevention, Non-Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study
Official Title: A Second Chance with Emergency Contraception (ECP): Reducing Unintended Pregnancy
Expected Total Enrollment: 1100
Study start: June 2001; Study completion: May 2004
ECPs can give women a “second chance” to prevent an unintended pregnancy that might arise because of lack or improper/defective use of contraceptives. By using ECP, a woman can reduce her risk of pregnancy by at least 75%; however, there is little information on what distribution patterns and other factors are most likely to encourage ECP use. This study will compare the use and cost of two ECP distribution patterns: advance provision and emergency provision. It will also identify environmental, situational, and behavioral factors associated with ECP acceptance and use.
Participants in this study will be recruited from four family planning clinics in the Philadelphia area and five family planning clinics in the Pittsburgh area. Participants from the Philadelphia clinics will be given ECPs as part of a regular clinic visit (advance provision); participants from the Pittsburgh clinics will be given ECPs on an emergency basis (emergent provision). Each participant will complete a short intake form and will be issued a pager. Participants will be paged every month over an 18-month period as a reminder to respond to a short automated telephone survey on ECP, contraceptives, and pregnancy status. Approximately half of the participants will be randomly selected to participate in in-depth interviews at study entry and Months 9 and 18. Clinic visit data will augment the surveys to verify use of the clinic and contraceptive method and to develop cost data.
Eligibility
Ages Eligible for Study: 15 Years - 39 Years, Genders Eligible for Study: Female
Accepts Healthy Volunteers
Criteria
Inclusion Criteria
- Patient at a participating clinic
Exclusion Criteria
- Pregnant
- Medical or surgical procedure preventing pregnancy (e.g., tubal ligation, hysterectomy)
- Norplant or IUDs
- Desires to become pregnant
Location Information
Pennsylvania
Family Planning Council, Philadelphia, Pennsylvania, 19102, United States
Family Health Council, Pittsburgh, Pennsylvania, 15222, United States
Paul G Whittaker, D.Phil., Principal Investigator
More Information
Record last reviewed: July 2003
Last Updated: October 13, 2004
Record first received: August 21, 2003
ClinicalTrials.gov Identifier: NCT00067509
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- All About Tubal Sterilization (Planned Parenthood Federation of America)
- Anticonceptivos Orales Combinados FAQ (Family Health International)

Not Signed In -


